Chemoinformaics analysis of 1,3-Dihydroxy-5,7,8-trimethoxy-2-methylanthraquinone
| Molecular Weight | 344.319 | nRot | 3 |
| Heavy Atom Molecular Weight | 328.191 | nRig | 18 |
| Exact Molecular Weight | 344.09 | nRing | 3 |
| Solubility: LogS | -4.592 | nHRing | 0 |
| Solubility: LogP | 3.149 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 12 |
| nHA | 7 | APOL | 46.3427 |
| nHD | 2 | BPOL | 22.9953 |
| QED | 0.751 |
| Synth | 2.528 |
| Natural Product Likeliness | 1.581 |
| NR-PPAR-gamma | 0.272 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.381 |
| Pgp-sub | 0.007 |
| HIA | 0.23 |
| CACO-2 | -5.171 |
| MDCK | 0.0000147 |
| BBB | 0.016 |
| PPB | 0.94558 |
| VDSS | 0.461 |
| FU | 0.0503774 |
| CYP1A2-inh | 0.518 |
| CYP1A2-sub | 0.969 |
| CYP2c19-inh | 0.047 |
| CYP2c19-sub | 0.33 |
| CYP2c9-inh | 0.494 |
| CYP2c9-sub | 0.613 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.305 |
| CYP3a4-inh | 0.41 |
| CYP3a4-sub | 0.4 |
| CL | 12.58 |
| T12 | 0.221 |
| hERG | 0.011 |
| Ames | 0.714 |
| ROA | 0.263 |
| SkinSen | 0.15 |
| Carcinogencity | 0.1 |
| EI | 0.924 |
| Respiratory | 0.121 |
| NR-Aromatase | 0.614 |
| Antiviral | Yes |
| Prediction | 0.828473 |